The role of IgG Fc receptors in antibody-dependent enhancement | Nature Reviews Immunology
Antibody-dependent enhancement (ADE) has been described as a mechanism that contributes to the pathogenesis of dengue virus infection. Limited evidence also suggests that it can also occur in other viral infections. Here, the authors explore the history of the ADE phenomenon, discuss the diversity of Fc effector functions and consider its potential relevance in the context of SARS-CoV-2 infection.
Subjects Translational immunology Viral infection Abstract Antibody-dependent enhancement (ADE) is a mechanism by which the pathogenesis of certain viral infections is enhanced in the presence of sub-neutralizing or cross-reactive non-neutralizing antiviral antibodies. In vitro modelling of ADE has attributed enhanced pathogenesis to Fcγ receptor (FcγR)-mediated viral entry, rather than canonical viral receptor-mediated entry. However, the putative FcγR-dependent mechanisms of ADE overlap with the role of these receptors in mediating antiviral protection in various viral infections, necessitat
related reading
- What is Fc receptors? - Creative Diagnosticscreative-diagnostics.com
- Fcγ receptors as regulators of immune responses | Nature Reviews Immunologynature.com
- The trinity of COVID-19: immunity, inflammation and interventionnature.com
- Interferon-alpha/beta receptor - Wikipediaen.wikipedia.org
- Vaccine Adjuvants: Putting Innate Immunity to Workncbi.nlm.nih.gov
- CG-dinucleotide suppression enables antiviral defense targeting non-self RNA - PMCncbi.nlm.nih.gov
- radvacradvac.org
- A primer on machine learning in antibody engineeringabhishaike.com
- Coronavirus envelope protein - Wikipediaen.wikipedia.org
- RNA editing enzymes: structure, biological functions and applicationscellandbioscience.biomedcentral.com
- Scientists make breakthrough towards ‘universal’ antiviral drugsgavi.org
- Thymosin alpha 1: A comprehensive review of the literaturencbi.nlm.nih.gov